샘플 요청 목록

 카트 문의
시장보고서
상품코드
1756476

기준 마커 시장 : 제품 유형별, 모달리티별, 암 유형별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Fiducial Marker Market, By Product, By Modality, By Cancer Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

기준 마커 시장 규모는 2024년 1억 6,890만 달러로 평가되었고, 2024-2032년 CAGR 8.70%로 확대될 전망입니다.

기준 마커 시장 - 시장 역학

영상 유도 치료의 채용 확대

종양학, 신경학 및 순환기학에서 이미지 유도 치료의 채택 확대는 기준 마커 시장의 주요 촉진요인입니다. 이러한 치료법에서는 치료의 정확도를 높이고 합병증을 줄이기 위해 해부학적 표적의 고정밀 위치 특정에 크게 의존하고 있습니다. 기준 마커는 특히 정위 방사선 수술이나 양성자 치료와 같은 복잡한 치료에 있어서 화상 데이터를 환자의 해부학적 구조에 맞추기 위한 신뢰할 수 있는 기준점으로서 중요한 역할을 하고 있습니다. 헬스케어 공급자들이 저침습으로 표적을 좁힌 치료를 점점 선호하게 되면서 기준 마커 수요가 급증하고 있습니다. 또한 MRI, CT, 하이브리드 PET/CT 시스템 등 영상 기술의 발전으로 다양한 임상 현장에서 기준 마커의 유용성이 확대되고 있습니다. 암이나 만성질환의 유병률 상승은 정확한 치료 계획의 필요성을 더욱 높이고, 기준 마커를 현대의 치료 워크플로우에 필수적인 도구로 자리매김하고 있습니다. 이 동향은 시장의 지속적인 성장을 촉진할 것으로 예상됩니다.

기준 마커 시장 - 주요 인사이트력

당사의 리서치 애널리스트에 따르면 세계의 기준 마커 시장은 2024-2032년 약 8.70%의 연평균 복합 성장률(CAGR)로 발전할 전망입니다.

제품별 부문에서는 2024년 금속 기반 마커 카테고리가 시장을 독점했습니다.

모달리티별로 초음파는 2024년에 가장 수익을 올렸습니다.

지역별로는 2024년 북미가 가장 수익이 높았습니다.

기준 마커 시장 - 세분화 분석

세계 기준 마커 시장은 네 가지 범주로 나뉩니다. 제품, 양식, 암 유형, 최종 사용자, 지역입니다.

기준 마커 시장은 제품별로 금속 기반 마커, 폴리머 기반 마커, 기타 기준 마커로 구분됩니다. 그 중에서도 금속 기반 마커는, 시인성이 뛰어나 CT, MRI, X선 등 다양한 화상 진단 모달리티에 적합하기 때문에, 시장을 석권할 것으로 예상됩니다. 통상, 금, 플래티넘, 스테인리스로 만들어지는 이러한 마커는, 높은 콘트라스트와 체내에서의 장기 안정성을 제공하기 위해, 방사선 치료 계획이나 화상 유도 수술 등, 반복 촬상을 필요로 하는 처치에 최적입니다. 내구성이 뛰어나고 이동 위험이 낮아 특히 종양학적 용도에서 수기의 정확성이 향상됩니다. 금속 기반의 기준 마커가 임상적으로 널리 받아들여지고 있는 것에 더해 치료 성적의 개선에 있어서의 그 유효성이 실증되고 있는 것이 시장에서의 리더쉽을 한층 더 지탱하고 있습니다. 정밀의료 및 저침습 치료의 수요가 계속 확대되는 가운데 금속 기반 마커의 견고한 성능과 신뢰성은 세계 헬스케어 시스템 전반에서 바람직한 선택지로 자리매김하고 있습니다.

기준 마커 시장을 암 유형별로 분류하면 전립선암, 폐암, 위암, 유방암, 기타 암 등이 있습니다. 이 중 전립선암이 가장 큰 점유율을 차지하고 있으며 앞으로도 지배적인 부문으로 남을 것으로 예상되고 있습니다. 이것은 전립선암 치료를 위한 화상유도방사선치료(IGRT)나 정위체방사선치료(SBRT)에서 기준 마커가 널리 사용되고 있는 것이 주요 원인입니다. 전립선은 방광이나 직장의 충만으로 인해 약간 이동하는 경향이 있어 정확한 위치 특정이 중요해집니다. 금속 기반의 기준 마커, 특히 금 마커는 각 치료 세션 중 정확한 타겟팅을 확실하게 하고 주위 조직에 손상을 최소화하면서 치료 성적을 개선하기 위해 전립선에 루틴에 내장되어 있습니다. 전립선암 세계의 이환율 상승과 선진적인 방사선 치료 기술에 대한 인식과 채택의 증가가 이 부문에서 기준 마커의 지속적인 수요를 견인하고 있습니다. 임상 프로토콜의 충실함과 상환 지원이, 이 시장의 우위성을 한층 더 높이고 있습니다.

기준 마커 시장 - 지리적 인사이트

기준 마커 시장은 북미, 아시아태평양, 라틴아메리카, 유럽, 중동 및 아프리카에 분포하고 있습니다. 이러한 지역은 비즈니스를 초래하고 있는 국가에 따라 더욱 분할됩니다.

북미는 기준 마커 시장에서 지배적인 지위를 차지하고 있어 그 주요인은 선진 헬스 케어 인프라, 영상 유도 치료의 높은 도입률, 암 치료 기술에의 다액의 투자입니다. 특히 미국은 암, 특히 전립선암이나 폐암의 유병률이 높고, 기준 마커와 같은 정확한 진단 및 치료 도구의 수요를 견인하고 있어 시장을 선도하고 있습니다. 게다가 확립된 헬스케어 시스템과 맞물려, 강력한 상환 시책이 방사선 치료나 외과 수술에 있어서의 피듀셜의 보급을 촉진하고 있습니다. 게다가 저침습 치료와 화상 기술에 관한 계속적인 연구와 기술 혁신이 시장의 성장을 계속 지탱하고 있습니다. 이 지역의 우위성은, 주요 시장 참가 기업의 존재도 지지하고 있어 채용이나 제품 개척을 한층 더 촉진하고 있습니다.

유럽도 기준 마커 시장에 크게 공헌하고 있는 주요 지역입니다. 선진적인 헬스 케어 기술의 채용과 정밀 의료 및 표적을 좁힌 암 치료의 중시의 고조가, 이 지역에서 기준 마커의 수요를 촉진하고 있습니다. 독일, 영국, 프랑스, 이탈리아 등의 국가들은 고도로 발달한 헬스케어 시스템과 암 이환율의 증가로 시장을 선도하고 있습니다. 유럽의 헬스케어 공급자는 특히 전립선암, 유방암, 폐암 등의 화상 유도 방사선 치료에 기준 마커를 이용하도록 되어 있습니다. 이 지역의 강력한 규제의 틀은, 임상 연구나 기술 혁신에 대한 지원과 함께, 기준 마커 사용의 성장에 길을 열고 있습니다. 게다가 저침습 치료에 대한 기호 고조 및 환자의 예후 개선에 대한 주목의 고조가, 시장을 한층 더 끌어올리고 있습니다.

기준 마커 시장 - 경쟁 구도

기준 마커 시장의 경쟁 역학은 기존 진출 기업과 기술 혁신에 주력하는 신흥 기업의 혼합에 의해 형성되고 있습니다. CIVCO Rad IoT herapy, Boston Scientific Corporation, IZI Medical Products, Medtronic, IBA 등 주요 기업들이 큰 점유율을 차지하고 있으며, 다양한 의료 영상 용도에 맞는 고품질의 피듀셜 마커를 폭넓게 제공하고 있습니다. 이러한 기업은 연구 개발에 고액의 투자를 실시해, 제품의 기능 강화, 정밀도 향상, 규제 준수를 도모하고 있습니다. Nanovi A/S나 Innovative Oncology Solutions와 같은 신규 참가 기업은 시인성과 매립 용이성을 강화한 차세대 피듀셜과 같은 선진 기술을 도입하고 있습니다. 이러한 경합 정세는, 이 부문에서 끊임없는 진보를 재촉해, 최종적으로 수기의 정밀도와 유효성을 향상시키는 혁신 환경을 양성하고 있습니다. 예를 들면, 메드트로닉은, 계속적인 연구 개발과 선진 화상 기술의 개발에 의해, 이 부문에서의 기술 혁신을 계속해, 시장에서의 리더쉽을 유지하고 있습니다.

목차

제1장 기준 마커 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 기준 마커의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 기준 마커 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 틀 분석

제5장 기준 마커 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아와 우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 기준 마커 시장 상황

  • 기준 마커 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥 기업의 분석

제7장 기준 마커 시장 : 제품별

  • 개요
    • 부문 점유율 분석 : 제품별
    • 금속 기반 마커
      • 순금 마커
      • 골드 콤비네이션 마커
      • 기타 금속 기반 마커
    • 폴리머 기반 마커
    • 기타 기준 마커

제8장 기준 마커 시장 : 모달리티별

  • 개요
    • 부문 점유율 분석 : 모달리티별
    • CT/CBCT
    • 초음파
    • MRI
    • 방사선요법

제9장 기준 마커 시장 : 암 유형별

  • 개요
    • 부문 점유율 분석 : 암 유형별
    • 전립선암
    • 폐암
    • 위암
    • 유방암
    • 기타 암

제10장 기준 마커 시장 : 최종 사용자별

  • 개요
    • 부문 점유율 분석 : 최종 사용자별
    • 병원 및 외래 시설
    • 독립 방사선 치료 센터
    • 암 연구센터

제11장 기준 마커 시장 : 지역별

  • 서문
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 : 기준 마커 산업

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • CIVCO RadIoTherapy
    • Boston Scientific Corporation
    • IZI Medical Products
    • IBA
    • Naslund Medical AB
    • Medtronic
    • Best Medical International, Inc.
    • Nanovi A/S
    • Carbon Medical Technologies
    • Eckert & Ziegler
    • Innovative Oncology Solutions
    • QlRad Inc.
    • Stellar Medical
    • JJ-Medtech
    • QFIX
    • 기타

제13장 애널리스트의 전방위 전망

AJY 25.07.02

REPORT HIGHLIGHT

Fiducial Marker Market size was valued at USD 168.9 Million in 2024, expanding at a CAGR of 8.70% from 2024 to 2032.

In healthcare, a fiducial marker is a reference point or object placed in or on the body to assist with precise localization during medical imaging, diagnostic procedures, or treatment planning. These markers are commonly used in radiology, radiation therapy, and surgical navigation to align imaging data with anatomical structures. Fiducial markers can be external (placed on the skin) or internal (implanted into tissues or tumors). Materials such as gold, carbon, or polymer are often used due to their visibility in imaging modalities like CT, MRI, and X-rays. In cancer treatment, for example, fiducial markers are implanted near tumors to help guide radiation beams with high accuracy, minimizing damage to healthy tissue. Similarly, in neurosurgery or robotic-assisted surgeries, fiducials provide reference points that enhance navigation systems. Their use significantly improves procedural precision, outcomes, and patient safety by ensuring accurate targeting and consistent positioning throughout treatment or surgical interventions.

Fiducial Marker Market- Market Dynamics

Increasing Adoption of Image-Guided Therapies

The growing adoption of image-guided therapies in oncology, neurology, and cardiology is a key driver for the fiducial markers market. These procedures rely heavily on high-precision localization of anatomical targets to enhance treatment accuracy and reduce complications. Fiducial markers play a crucial role by serving as reliable reference points for aligning imaging data with the patient's anatomy, especially in complex interventions such as stereotactic radiosurgery or proton therapy. As healthcare providers increasingly prefer minimally invasive and targeted treatment options, the demand for fiducials has surged. Moreover, advancements in imaging technologies, including MRI, CT, and hybrid PET/CT systems, have expanded the utility of fiducial markers across diverse clinical settings. The rising prevalence of cancer and chronic diseases further contributes to the need for accurate treatment planning, positioning fiducial markers as an essential tool in modern therapeutic workflows. This trend is expected to drive sustained market growth.

FIDUCIAL MARKER Market- Key Insights

According to our research analyst, the global Fiducial Marker Market is expected to develop at a CAGR of approximately 8.70% between 2024-2032.

Segmented by Product in 2024, the Metal-Based Markers category dominated the market.

Based on Modality, the Ultrasound generated the most income in 2024.

Based on region, in 2024, North America was the region with the highest revenue.

Fiducial Marker Market- Segmentation Analysis:

The global Fiducial Marker market is divided into four categories: Product, Modality, Cancer Type, End User and Region.

The fiducial markers market is segmented by product into Metal-Based Markers, Polymer-Based Markers, and Other Fiducial Markers. Among these, Metal-Based Markers are expected to dominate the market due to their superior visibility and compatibility with various imaging modalities such as CT, MRI, and X-ray. Typically made from gold, platinum, or stainless steel, these markers provide high contrast and long-term stability within the body, making them ideal for procedures requiring repeated imaging, such as radiotherapy planning and image-guided surgery. Their durability and low risk of migration enhance procedural accuracy, particularly in oncology applications. The widespread clinical acceptance of metal-based fiducials, along with their proven efficacy in improving treatment outcomes, further supports their market leadership. As the demand for precision medicine and minimally invasive treatments continues to grow, the robust performance and reliability of metal-based markers position them as the preferred choice across global healthcare systems.

The fiducial markers market, when segmented by cancer type, includes Prostate Cancer, Lung Cancer, Gastric Cancer, Breast Cancer, and Other Cancers. Among these, Prostate Cancer accounts for the largest share and is expected to remain the dominant segment. This is largely due to the widespread use of fiducial markers in image-guided radiation therapy (IGRT) and stereotactic body radiation therapy (SBRT) for prostate cancer treatment. The prostate gland tends to shift slightly due to bladder and rectal filling, making accurate localization critical. Metal-based fiducial markers, especially gold markers, are routinely implanted in the prostate to ensure precise targeting during each treatment session, improving outcomes while minimizing damage to surrounding tissues. The rising global incidence of prostate cancer, along with increased awareness and adoption of advanced radiotherapy techniques, is driving the sustained demand for fiducial markers in this segment. Enhanced clinical protocols and reimbursement support further contribute to its market dominance.

Fiducial Marker Market- Geographical Insights

Geographically, the Fiducial Marker Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America holds a dominant position in the fiducial marker market, primarily driven by advanced healthcare infrastructure, high adoption rates of image-guided therapies, and significant investments in cancer treatment technologies. The United States, in particular, leads the market due to the high prevalence of cancer, especially prostate and lung cancer, which drives the demand for accurate diagnostic and therapeutic tools such as fiducial markers. Additionally, strong reimbursement policies, coupled with a well-established healthcare system, facilitate the widespread usage of fiducials in radiotherapy and surgical procedures. Furthermore, ongoing research and innovation in minimally invasive treatments and imaging technologies continue to support market growth. The region's dominance is also supported by the presence of key market players, further driving adoption and product development.

Europe is another key region contributing significantly to the fiducial marker market. The adoption of advanced healthcare technologies, coupled with a growing emphasis on precision medicine and targeted cancer therapies, has fostered the demand for fiducial markers in the region. Countries such as Germany, the UK, France, and Italy lead the market, owing to their highly developed healthcare systems and increasing cancer incidence rates. European healthcare providers are increasingly utilizing fiducial markers in image-guided radiation therapy, particularly for prostate, breast, and lung cancers. The region's strong regulatory frameworks, along with the support for clinical research and innovation, have paved the way for the growth of fiducial marker usage. Furthermore, the increasing preference for minimally invasive treatments and the growing focus on improving patient outcomes further boost the market.

Fiducial Marker Market- Competitive Landscape:

The competitive dynamics of the Fiducial Marker market are shaped by a mix of established players and emerging companies focused on innovation. Key market players such as CIVCO Radiotherapy, Boston Scientific Corporation, IZI Medical Products, Medtronic, and IBA hold significant market shares, offering a wide range of high-quality fiducial markers tailored for various medical imaging applications. These companies invest heavily in research and development to enhance product features, improve precision, and ensure regulatory compliance. New entrants, like Nanovi A/S and Innovative Oncology Solutions, are introducing advanced technologies such as next-gen fiducials with enhanced visibility and ease of implantation. This competitive landscape drives continuous advancements in the sector, fostering an environment of innovation that ultimately improves the accuracy and effectiveness of procedures. For instance, Medtronic continues to innovate in the field with its ongoing R&D and the development of advanced imaging technologies, maintaining its leadership in the market.

Recent Developments:

In October 2023, Nanovi A/S, a Danish medical device company specializing in liquid fiducial markers, was acquired by CQ Medical (formerly CIVCO Radiotherapy and Qfix). This acquisition integrates Nanovi's innovative BioXmark(R) technology into CQ Medical's portfolio, enhancing its offerings in high-precision radiation therapy. BioXmark(R) is a biodegradable liquid marker that provides excellent imaging visibility with minimal artifacts, making it suitable for various imaging modalities, including CT and MRI.

In June 2023, CIVCO Radiotherapy expanded its portfolio with the acquisition of Best Medical International, Inc., further strengthening its position in the fiducial marker market.

In February 2022, Boston Scientific Corporation launched a new fiducial marker designed for enhanced MRI compatibility, offering improved patient safety and treatment accuracy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FIDUCIAL MARKER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • CIVCO Radiotherapy
  • Boston Scientific Corporation
  • IZI Medical Products
  • IBA
  • Naslund Medical AB
  • Medtronic
  • Best Medical International, Inc.
  • Nanovi A/S
  • Carbon Medical Technologies
  • Eckert & Ziegler
  • Innovative Oncology Solutions
  • QlRad Inc.
  • Stellar Medical
  • JJ-Medtech
  • QFIX
  • Others

GLOBAL FIDUCIAL MARKER MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Metal-Based Markers
  • Pure Gold Markers
  • Gold Combination Markers
  • Other Metal-Based Markers
  • Polymer-Based Markers
  • Other Fiducial Markers

GLOBAL FIDUCIAL MARKER MARKET, BY MODALITY - MARKET ANALYSIS, 2019 - 2032

  • CT/CBCT
  • Ultrasound
  • MRI
  • Radiotherapy

GLOBAL FIDUCIAL MARKER MARKET, BY CANCER TYPE - MARKET ANALYSIS, 2019 - 2032

  • Prostate Cancer
  • Lung Cancer
  • Gastric Cancer
  • Breast Cancer
  • Other Cancers

GLOBAL FIDUCIAL MARKER MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Outpatient Facilities
  • Independent Radiotherapy Centers
  • Cancer Research Centers

GLOBAL FIDUCIAL MARKER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fiducial Marker Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fiducial Marker Market Snippet by Product
    • 2.1.2. Fiducial Marker Market Snippet by Modality
    • 2.1.3. Fiducial Marker Market Snippet by Cancer Type
    • 2.1.4. Fiducial Marker Market Snippet by End User
    • 2.1.5. Fiducial Marker Market Snippet by Country
    • 2.1.6. Fiducial Marker Market Snippet by Region
  • 2.2. Competitive Insights

3. Fiducial Marker Key Market Trends

  • 3.1. Fiducial Marker Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fiducial Marker Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fiducial Marker Market Opportunities
  • 3.4. Fiducial Marker Market Future Trends

4. Fiducial Marker Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fiducial Marker Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Fiducial Marker Market Landscape

  • 6.1. Fiducial Marker Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fiducial Marker Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Metal-Based Markers
      • 7.1.2.1. Pure Gold Markers
      • 7.1.2.2. Gold Combination Markers
      • 7.1.2.3. Other Metal-Based Markers
    • 7.1.3. Polymer-Based Markers
    • 7.1.4. Other Fiducial Markers

8. Fiducial Marker Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2023 & 2032 (%)
    • 8.1.2. Ct/Cbct
    • 8.1.3. Ultrasound
    • 8.1.4. MRI
    • 8.1.5. Radiotherapy

9. Fiducial Marker Market - By Cancer Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 9.1.2. Prostate Cancer
    • 9.1.3. Lung Cancer
    • 9.1.4. Gastric Cancer
    • 9.1.5. Breast Cancer
    • 9.1.6. Other Cancers

10. Fiducial Marker Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Hospitals & Outpatient Facilities
    • 10.1.3. Independent Radiotherapy Centers
    • 10.1.4. Cancer Research Centers

11. Fiducial Marker Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Fiducial Marker Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Fiducial Marker Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Fiducial Marker Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Fiducial Marker Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Fiducial Marker Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fiducial Marker Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. CIVCO Radiotherapy
    • 12.2.2. Boston Scientific Corporation
    • 12.2.3. IZI Medical Products
    • 12.2.4. IBA
    • 12.2.5. Naslund Medical AB
    • 12.2.6. Medtronic
    • 12.2.7. Best Medical International, Inc.
    • 12.2.8. Nanovi A/S
    • 12.2.9. Carbon Medical Technologies
    • 12.2.10. Eckert & Ziegler
    • 12.2.11. Innovative Oncology Solutions
    • 12.2.12. QlRad Inc.
    • 12.2.13. Stellar Medical
    • 12.2.14. JJ-Medtech
    • 12.2.15. QFIX
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제